Erratum to: The therapeutic efficacy of intensive medical therapy in ameliorating high-density lipoprotein dysfunction in subjects with type two diabetes
© The Author(s). 2016
Published: 9 November 2016
The original article was published in Lipids in Health and Disease 2016 15:141
After publication of the original article , it came to the authors’ attention that a source of funding was not disclosed in the Declarations section of the paper. The study was in part supported by the American Diabetes Association (1-15-IN-31). The Funding section of the original article should have acknowledged this grant.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Kashyap S, Kheniser K, Li L, Bena J, Kasumov T. The therapeutic efficacy of intensive medical therapy in ameliorating high-density lipoprotein dysfunction in subjects with type two diabetes. Lipids Health Dis. 2016;15:141. doi:https://doi.org/10.1186/s12944-016-0314-4.View ArticlePubMedPubMed CentralGoogle Scholar